Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

INTRODUCTION. Despite the availability of several therapeutic options for metastatic breast cancer (MBC), no robust predictive factors are available to help clinical decision making. Nevertheless, a decreasing benefit from first line to subsequent lines of treatment is commonly observed. The aim of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Principais autores: Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492241/
https://ncbi.nlm.nih.gov/pubmed/26018662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados